Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

How much does stem cell treatment for cerebral palsy cost?

At Stem Cell Mexico, stem cell treatment for cerebral palsy (CP) is quoted individually, and the exact figure is confirmed after a medical evaluation; young children with lower weight-based doses may fall at the lower end.

Free Consultation
Brain location on a neutral human figure

The price depends on the patient's age and body weight (cell doses are calculated per kilogram), the type and severity of CP, the goals of treatment, the number of cells recommended, the route of administration, whether more than one session is planned and the level of support needed during the stay, such as a caregiver, mobility equipment or extended observation. Before any deposit is paid, the family receives a written quote that lists exactly what is included.

Most people who ask this question are parents or caregivers. You want to know not only what it costs, but whether it can help, how safe it is and how it fits with the therapies your family already relies on. This guide answers those questions with care and clarity.

Why the price varies within the range

Cerebral palsy describes a group of conditions, not one single disorder, and plans need to reflect that.

Age and weight

Children and adults receive doses adjusted to body weight. A young child, a teenager and an adult with CP will have very different protocols and costs.

Type of CP

  • Spastic CP, the most common type, causes stiff muscles and exaggerated reflexes.
  • Dyskinetic CP involves involuntary movements.
  • Ataxic CP affects balance and coordination.
  • Mixed CP combines features.

The body areas affected (one side, both legs or the whole body) and associated conditions also matter.

Functional level

The Gross Motor Function Classification System (GMFCS) describes mobility from level I (walks without limitations) to level V (severe limitations, uses a wheelchair with full assistance). Goals and support needs differ greatly between levels.

Support needs

Some patients require a caregiver in the room, adapted transportation, feeding support or medications on a strict schedule. These accommodations are planned and included in the quote when needed.

What a typical quote includes

Each plan is personalized, but generally includes:

  • Consultation with the doctor and stem cell specialist, reviewing diagnosis, brain imaging if available, therapy reports, seizure history and medications.
  • Pre-treatment laboratory testing appropriate to the patient's age and health.
  • Allogeneic mesenchymal stromal cells (MSCs) derived from donated umbilical cord tissue, prepared for your scheduled date.
  • Administration according to the plan under medical supervision.
  • Medical observation with nursing care, ground transportation between the San Diego area and the clinic, a patient coordinator and follow-up.

Flights, additional hotel nights and lodging for family members are usually separate unless listed.

What cerebral palsy is and how it is managed today

According to the U.S. Centers for Disease Control and Prevention (CDC), cerebral palsy is the most common motor disability in childhood. It is caused by abnormal development of, or damage to, the parts of the brain that control movement, balance and posture, usually before or around birth. The brain injury itself does not get worse over time, but its effects on muscles, joints and daily function can change as a child grows.

Cerebral palsy is a long-term condition, and meaningful gains in function, comfort and independence are possible with individualized care. The CDC and international guidelines emphasize early, goal-directed intervention:

  • Physical, occupational and speech therapy, ideally intensive and goal-directed.
  • Medications to manage spasticity, such as oral drugs or botulinum toxin injections.
  • Orthopedic care, including braces and, in some cases, surgery.
  • Neurosurgical options such as selective dorsal rhizotomy for selected children.
  • Assistive technology and educational support.

Regenerative therapy is being studied as a way to complement these approaches, particularly by supporting neuroplasticity and the biological environment in which rehabilitation takes place. Families are encouraged to continue their therapy programs so any gains can be translated into daily function.

How cell therapy is thought to help in CP

Because CP results from an earlier brain injury, the goal of cell therapy is not to replace large areas of brain tissue. Research suggests cells may:

  • Reduce inflammation in the brain and modulate immune activity.
  • Release neurotrophic factors that support neurons and the formation of new connections.
  • Promote neuroplasticity, especially in young children whose brains are still developing rapidly.
  • Support white matter connectivity, which some imaging studies have explored.

These effects are thought to work best when combined with intensive rehabilitation, which helps the brain use new or strengthened connections.

What the evidence says

Meta-analysis of randomized trials: A 2019 systematic review and meta-analysis in the World Journal of Stem Cells (Eggenberger and colleagues) analyzed five randomized controlled trials with 282 patients. Children who received stem cell therapy showed a statistically significant improvement in gross motor function (GMFM) compared with those who received standard care alone. Serious adverse events were rare and similar between groups. The authors noted that mesenchymal stem cells appeared among the most promising cell types.

Dose may matter: A randomized, placebo-controlled trial at Duke University, published in Stem Cells Translational Medicine in 2017 (Sun, Kurtzberg and colleagues), studied 63 young children with CP who received an IV infusion of their own banked umbilical cord blood. Children who received an adequate dose (about 25 million cells per kilogram or more) improved more in motor function at one year than expected, and imaging showed changes in brain connectivity. This study highlighted the importance of dose and of careful measurement.

What this means for families: Clinical research shows a reasonable safety profile and measurable improvements in motor function for some children, particularly when combined with rehabilitation. Results vary between children. Different cell types (autologous cord blood, umbilical cord MSCs, bone marrow cells) and routes have been studied, and results from one should not be assumed for another.

Regulatory context

No stem cell product is approved by the FDA for cerebral palsy. In Mexico, cell therapies are regulated by COFEPRIS and must come from licensed laboratories.

Making an informed decision as a family

Choosing a regenerative treatment for a child is a personal decision, and it is normal to have questions. The medical team reviews the child's history, functional level, therapies and family priorities to define realistic goals and determine whether the profile aligns with the type of benefit being studied. Involving your child's neurologist, pediatrician and therapists can make the plan stronger, especially when everyone is measuring the same abilities before and after treatment. Families can also plan around school, therapy and travel so the experience is as comfortable and useful as possible.

Who may be a candidate

Evaluation considers:

  • Confirmed CP diagnosis, type and GMFCS level.
  • Age, weight and general health.
  • Seizure control (uncontrolled seizures may require stabilization first).
  • No active infection, and stable respiratory and nutritional status.
  • Clear, measurable goals and continued access to therapy.

What results families commonly ask about

What kinds of changes can families look for? When improvements occur, they are usually gradual and specific: better head or trunk control, smoother movements, less stiffness, improved hand use, attention or communication. The most useful goals are the ones that can be measured against the child's own baseline.

When might we notice changes? Families and therapists usually evaluate progress over three to twelve months.

How do we measure progress? With standardized tools such as the GMFM, therapist assessments, videos and goal-based scales, compared with a baseline recorded before treatment.

What can affect outcomes

  • Age at treatment, with younger children often showing more plasticity.
  • Type and severity of CP.
  • Intensity and consistency of rehabilitation after treatment.
  • Nutrition, sleep, seizure control and overall health.
  • Cell dose and route.

Preparing for treatment

Share medical records, brain imaging, therapy reports and a complete medication list, including anti-seizure drugs. Tell us about feeding methods, communication needs, sensory sensitivities and equipment so the team can make the visit as comfortable as possible. Recording baseline videos and therapist scores helps measure change. Plan travel with rest time, as unfamiliar environments can be tiring.

Risks and limitations

IV infusions of umbilical cord MSCs have generally been well tolerated in pediatric and adult studies. Possible effects include temporary fever, irritability, headache or fatigue, and rare allergic reactions. Any procedure requiring sedation carries its own small risks, which are reviewed in advance. The main limitation is variability in benefit.

Questions to ask during your evaluation

  • What specific goals are realistic for my child's type and level of CP?
  • How is the dose calculated, and what route will be used?
  • How should we coordinate with our therapists?
  • How will progress be measured?
  • What exactly is included in our quote?

Bottom line

Stem cell treatment for cerebral palsy at Stem Cell Mexico is quoted individually, based on age, weight, type of CP, goals and support needs. Research shows meaningful motor improvements for some patients and a good safety profile. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your child's or your own condition, goals and medical history, and gives your family a written quote before you decide.

References

  1. U.S. Centers for Disease Control and Prevention (CDC): Treatment and intervention for cerebral palsy (opens in a new tab)
  2. Eggenberger S et al. Stem cell treatment and cerebral palsy: systemic review and meta-analysis. World Journal of Stem Cells, 2019 (opens in a new tab)
  3. Sun JM et al. Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: a randomized, placebo-controlled trial. Stem Cells Translational Medicine, 2017 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation